The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression

I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany)

Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Session: Novel mechanisms and management of paediatric asthma
Session type: E-poster session
Number: 1220
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany). The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression. 1220

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process
Source: Eur Respir J 2004; 24: Suppl. 48, 592s
Year: 2004

Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

The influence of smoking on the level of proinflammatory cytokines in patients with COPD
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012


Involvement of nitric oxide, proinflammatory cytokines and effector cells in the inflammatory process in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


An evaluation of circulating cytokines milieu in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 311s
Year: 2002

Microparticles from OSA patients induce hyper-reactivity through up-regulation of pro-inflammatory proteins
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011


The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


The role of pro-inflammatory cytokine activation in perioperative lung injury
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004

The levels of proinflammatory cytokines in patients with dust-induced lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 536s
Year: 2001

Chronic obstructive pulmonary disease is characterized with suppressed lipoxin A4 and increased lipoxin receptor expression in lungs
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012

The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 550s
Year: 2006

Disease and stimulus specific pro-inflammatory cytokine secretion by human fibroblast of asthma patients
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011

Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003



Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation.
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018



Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006

Increased TGF-β-inducible early gene (TIEG) in human eosinophils stimulated by Th-2 type inflammatory cytokines
Source: Eur Respir J 2005; 26: Suppl. 49, 659s
Year: 2005

An update on anti-inflammatory endogenous mediators
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005